Head-to-Head Comparison
| Criteria | Berberine | Red Yeast Rice for Cholesterol | Winner |
|---|---|---|---|
| LDL Reduction | 15–25% reduction at 500 mg 2–3x/day | 20–30% reduction at 1,200 mg/day (with monacolin K) | Red Yeast Rice for Cholesterol |
| Triglyceride Reduction | 20–35% reduction in clinical trials | 10–20% reduction as secondary effect | Berberine |
| Blood Sugar Effects | Significant: 0.5–0.9% HbA1c reduction | Minimal direct effect on blood glucose | Berberine |
| Drug Interactions | Moderate: CYP2D6/3A4 inhibitor | Significant: contains monacolin K with statin-like interactions | Berberine |
| Safety Profile | GI side effects; generally well-tolerated | Statin-like risks: myopathy, hepatotoxicity possible; variable monacolin K content | Berberine |